Sanofi Buys Hepatitis Vaccine Maker Dynavax For $2.2B
French pharmaceutical giant Sanofi SA said Wednesday that it will buy Dynavax Technologies, a U.S. vaccine developer, for $2.2 billion in a recommended cash deal to expand its adult immunization products....To view the full article, register now.
Already a subscriber? Click here to view full article